The "Armed Virus" Revolution: Is 2026 the Year We Start Shipping "Pharmacy-in-a-Virus"?
A major shift in the 2026 global industry is the record-breaking adoption of "Armed Oncolytic Viruses." This year, to cater to the need for multi-layered attacks, the Oncolytic Virotherapy Market has transitioned to viruses that are genetically engineered to carry "payloads" like cytokines (GM-CSF) or bispecific antibodies. This level of "Self-Manufacturing Therapy" is the new gold standard,...
0 Comments 0 Shares 27 Views 0 Reviews